Nebu-Flow

Investor: Scottish Enterprise

Nebu-Flow, a Glasgow-based innovator in respiratory drug delivery, has successfully secured a £2 million grant from Scottish Enterprise. This funding will be instrumental in advancing the company's novel acoustic frequency nebuliser from its current prototype stage to a fully engineered, market-ready product, addressing critical needs in delivering advanced respiratory medicines.Summary of transaction details:Value: £2,000,000Sector: Healthcare & BiotechAdvisor: Not mentionedKey Entities: Nebu-Flow (Target), Scottish Enterprise (Investor)Location: Glasgow, ScotlandNote: This strategic investment by Scottish Enterprise underscores the significant potential of Nebu-Flow's technology to transform respiratory drug delivery. The grant aims to support final design work, performance testing, and critical regulatory approvals, facilitating the device's entry into the UK, European, and United States markets, ultimately improving patient outcomes globally.

Investor: Foresight WAE Technology (FWT) Funds, Ascension VC, Scottish Enterprise, SCVC, Conduit EIS Impact Fund, SIS Ventures